![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Bladder Cancer |
Free Subscription
1 Aging (Albany NY) |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Collaborating single-cell and bulk RNA sequencing for comprehensive
characterization of the bladder cancer intratumor heterogeneity and prognostic
model development for bladder cancer.
Aging (Albany NY). 2023;15.
PubMed
Abstract available
Enfortumab vedotin as a salvage option as 5th line therapy for metastatic
urothelial bladder cancer.
Aktuelle Urol. 2023 Nov 14. doi: 10.1055/a-2148-5799.
PubMed
Abstract available
Gene expression profiles to analyze the anticancer and carcinogenic effects of
arsenic in bladder cancer.
Am J Transl Res. 2023;15:5984-5996.
PubMed
Abstract available
The vascular and morphological characteristics of tumors under narrow-band
imaging as predictors for the grade and stage of bladder cancer: a prospective
and multi-center study.
Ann Med. 2023;55:2281656.
PubMed
Abstract available
Three versus four cycles of neoadjuvant chemotherapy for muscle-invasive bladder
cancer: a systematic review and meta-analysis.
Ann Med. 2023;55:2281654.
PubMed
Abstract available
Exploring the Shared Gene Signatures and Molecular Mechanisms between Bladder
Urothelial Carcinoma and Metabolic Syndrome.
Arch Esp Urol. 2023;76:605-621.
PubMed
Abstract available
Postoperative Metachronous Metastasis of Bladder Cancer to Penis: A Case Report.
Arch Esp Urol. 2023;76:622-626.
PubMed
Abstract available
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic
body radiation therapy in patients with metastatic multiorgan cancer.
BMC Cancer. 2023;23:1080.
PubMed
Abstract available
Assessing the prognostic impact of prostatic urethra involvement and developing a
nomogram for T1 stage bladder cancer.
BMC Urol. 2023;23:182.
PubMed
Abstract available
Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive
urothelial bladder cancer: diagnostic performance and outcomes using biparametric
vs. multiparametric MRI.
Cancer Imaging. 2023;23:110.
PubMed
Abstract available
Exosomal Long Non-Coding Ribonucleic Acid Ribonuclease Component of Mitochondrial
Ribonucleic Acid Processing Endoribonuclease Is Defined as a Potential
Non-Invasive Diagnostic Biomarker for Bladder Cancer and Facilitates
Tumorigenesis via the miR-206
Cancers (Basel). 2023;15:5305.
PubMed
Abstract available
FAM111B Acts as an Oncogene in Bladder Cancer.
Cancers (Basel). 2023;15:5122.
PubMed
Abstract available
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and
Treatment Outcomes with Erdafitinib: A Real-World Experience.
Clin Cancer Res. 2023;29:4586-4595.
PubMed
Abstract available
Association of Molecular Subtypes with Pathologic Response, PFS and OS in a Phase
II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-Invasive Bladder
Cancer.
Clin Cancer Res. 2023 Nov 15. doi: 10.1158/1078-0432.CCR-23-0602.
PubMed
Abstract available
A New Scoring System to Differentiate Bladder Cancer from Intravesical Prostatic
Protrusion in the Bladder Neck: BCa-IPP Score.
Curr Med Imaging. 2023 Nov 10. doi: 10.2174/0115734056241577231023064014.
PubMed
Abstract available
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment
Landscape: Insights from Italian Experts.
Curr Oncol Rep. 2023;25:1345-1362.
PubMed
Abstract available
Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and
Future Perspectives.
Curr Oncol Rep. 2023;25:1327-1344.
PubMed
Abstract available
A sialyltransferases-related gene signature serves as a potential predictor of
prognosis and therapeutic response for bladder cancer.
Eur J Med Res. 2023;28:515.
PubMed
Abstract available
Identification and validation of a dysregulated TME-related gene signature for
predicting prognosis, and immunological properties in bladder cancer.
Front Immunol. 2023;14:1213947.
PubMed
Abstract available
Identification of tryptophan metabolism- and immune-related genes signature and
prediction of immune infiltration landscape in bladder urothelial carcinoma.
Front Immunol. 2023;14:1283792.
PubMed
Abstract available
The Role of Longevity Assurance Homolog 2/Ceramide Synthase 2 in Bladder Cancer.
Int J Mol Sci. 2023;24:15668.
PubMed
Abstract available
Gelsolin, an Actin-Binding Protein: Bioinformatic Analysis and Functional
Significance in Urothelial Bladder Carcinoma.
Int J Mol Sci. 2023;24:15763.
PubMed
Abstract available
Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for
Urological Cancers.
Int J Mol Sci. 2023;24:15795.
PubMed
Abstract available
Chitinase 3-like-1 Expression in the Microenvironment Is Associated with
Neutrophil Infiltration in Bladder Cancer.
Int J Mol Sci. 2023;24:15990.
PubMed
Abstract available
Urinary markers for bladder cancer diagnosis: A review of current status and
future challenges.
Int J Urol. 2023 Nov 15. doi: 10.1111/iju.15338.
PubMed
Abstract available
Editorial comment-Risk stratification and management of nonmuscle-invasive
bladder cancer: A physician survey in six Asia-Pacific territories.
Int J Urol. 2023 Nov 15. doi: 10.1111/iju.15340.
PubMed
Epigenetic alterations in urothelial bladder cancer associated with disease
outcomes.
Int J Urol. 2023 Nov 14. doi: 10.1111/iju.15335.
PubMed
Abstract available
Identification of potential phytochemical for the inhibition of non-muscle
invasive bladder cancer (NMIBC).
J Biomol Struct Dyn. 2023 Nov 14:1-9. doi: 10.1080/07391102.2023.2280914.
PubMed
Abstract available
Evidence-Based Analysis of the Critical Steps of Radical Cystectomy for Bladder
Cancer.
J Clin Med. 2023;12:6845.
PubMed
Abstract available
The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer
Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A
Prospective Study.
J Clin Med. 2023;12:6749.
PubMed
Abstract available
Robot-Assisted Repair of Ureteroenteric Strictures After Cystectomy with Urinary
Diversion: Technique Description and Outcomes from the European Robotic Urology
Section Scientific Working Group.
J Endourol. 2023;37:1209-1215.
PubMed
Abstract available
Efficient Augmented Intelligence Framework for Bladder Lesion Detection.
JCO Clin Cancer Inform. 2023;7:e2300031.
PubMed
Abstract available
Identification of the role of MCM6 in bladder cancer prognosis, immunotherapy
response, and in vitro experimental investigation using multi-omics analysis.
Life Sci. 2023;335:122253.
PubMed
Abstract available
LncRNA UCA1 could regulate the progression of neuropathic pain by regulating
miR-135a-5p.
Mutat Res. 2023;827:111833.
PubMed
Abstract available
BK Polyomavirus-Associated Urothelial Carcinoma of the Bladder with a Background
of BK Polyomavirus Nephropathy in a Kidney Transplant Recipient.
Nephron. 2023;147 Suppl 1:53-60.
PubMed
Abstract available
Invasive urothelial carcinoma with chordoid features or abundant myxoid stroma: A
reappraisal of morphologic spectrum and risk stratification based on molecular
classification.
Pathol Res Pract. 2023;251:154839.
PubMed
Abstract available
Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma
of the bladder with mismatch repair protein deficiency.
Pol J Pathol. 2023;74:161-170.
PubMed
Abstract available
Initial management and survival of patients with primary metastatic bladder
cancer before the immunotherapy era: a population-based study from Norway.
Scand J Urol. 2023;58:101-108.
PubMed
Abstract available
Nitrogen isotopic composition as a gauge of tumor cell anabolism-to-catabolism
ratio.
Sci Rep. 2023;13:19796.
PubMed
Abstract available
Tumor microenvironment heterogeneity in bladder cancer identifies biologically
distinct subtypes predicting prognosis and anti-PD-L1 responses.
Sci Rep. 2023;13:19563.
PubMed
Abstract available
HMG co-reductase expression and response to intravesical Bacillus Calmette-Guerin
in patients with high grade non-muscle invasive urinary bladder cancer receiving
statins.
Scott Med J. 2023 Nov 13:369330231213935. doi: 10.1177/00369330231213935.
PubMed
Abstract available
Engineered Macrophages Tune Intratumoral Cytokines through Precisely Controlled
Self-Pyroptosis to Enhance Bladder Cancer Immunotherapy.
Small. 2023 Nov 14:e2306699. doi: 10.1002/smll.202306699.
PubMed
Abstract available
Optimizing outcomes for high-risk, non-muscle-invasive bladder cancer: The
evolving role of PD-(L)1 inhibition.
Urol Oncol. 2023 Nov 13:S1078-1439(23)00342.
PubMed
Abstract available
Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect
in bladder cancer.
Urol Oncol. 2023 Nov 10:S1078-1439(23)00324.
PubMed
Abstract available
Thank you for your interest in scientific medicine.